Jin Medical International (ZJYL) Invested Capital (2022 - 2025)

Jin Medical International's Invested Capital history runs 4 years deep, the most recent figure standing at $21.8 million for Q3 2025.

• In Q3 2025, Invested Capital fell 23.66% year-over-year to $21.8 million; the TTM figure through Sep 2025 stood at $21.8 million (down 23.66% YoY), while the FY2025 annual figure was $21.8 million, down 23.66% from the prior year.
• Invested Capital came in at $21.8 million for Q3 2025 at Jin Medical International, down from $28.6 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $28.6 million in Q3 2024 to a low of $15.2 million in Q3 2022.
• A 4-year average of $22.4 million and a median of $22.9 million in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital soared 57.39% in 2023 and retreated 23.66% in 2025, its largest moves.
• Jin Medical International's Invested Capital stood at $15.2 million in 2022, then surged by 57.39% to $24.0 million in 2023, then gained by 19.07% to $28.6 million in 2024, then fell by 23.66% to $21.8 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $21.8 million, $28.6 million, and $24.0 million for Q3 2025, Q3 2024, and Q3 2023 respectively.

Peer Comparison